BeStock  
Markets › Compare › BDNNY vs BBIO

BDNNY vs BBIO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BDNNY · BOLIDEN AB UNSP ADR EACH REPR 2 ORD$84.53 ▼ 6.84%
BBIO · BridgeBio Pharma$76.03 ▼ 2.75%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

84110136162188Nov 24, '25May 26, '26Nov 20, '26
  • BDNNY -2.1%
  • BBIO +7.1%

Head to head

MetricBDNNYBBIO
Price$84.53$76.03
Change today▼ 6.84%▼ 2.75%
Market cap$14.81B$14.81B
Return, 3 months-29.5%-6.2%
Return, year to date-21.9%-0.6%
Return, 1 year+0.6%+11.6%
P/E (TTM)7.9–
P/B0.3-5.7
P/E percentile vs own 5y–1st
Dividend yield2.82%–
Revenue growth (YoY, latest qtr)–+192.6%
Net profit growth (YoY)–+67.3%
Gross margin–94.3%
Operating margin–-37.3%
Net margin–-62.6%
Return on equity––
Analyst target vs. price–+44.7%
Analyst buy share–94%
RSI (14)2955
30-day volatility49.8%37.8%
Max drawdown, 1 year-46.3%-29.8%
Trend readStrong downtrendLeaning bullish
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BDNNY is the largest of the group by market value.
  • BBIO has returned the most over the past year.
  • BBIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top